3M Co
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 13/3041% above fair value
$178.36+4.02 (+2.31%)
Close on Nov 2, 2026Market cap $91.98BP/E 31.7Yield 1.64%
3M Drug Delivery Division (Divested May 2020) by Year
Drug Delivery Division (Divested May 2020) — Net Sales ($M) ($M)
3M Drug Delivery Division (Divested May 2020): $146M in 2020, down 60.8% from a year earlier. No newer figure appears in the documents we track.
Latest, 2020
146
Period ended Dec 31, 2020
Change on a year earlier
-60.8%
372 in 2019
History
3 years
Since 2018
Sources
3
Documents cited below
Where the 2020 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Drug Delivery Division (Divested May 2020) — Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| 2020 | Dec 31, 2020 | 146 | -60.8% | SEC Form 10-K (filed 2023-02-08) ↗ |
| 2019 | Dec 31, 2019 | 372 | -8.6% | SEC Form 10-K (filed 2022-02-09) ↗ |
| 2018 | Dec 31, 2018 | 407 | – | SEC Form 10-K (filed 2021-02-04) ↗ |
Cite this data
StockData. (2026). 3M Drug Delivery Division (Divested May 2020) ($M), annual 2018–2020 [Data set]. Compiled from 3M SEC filings and investor materials. https://stockdatahq.com/stocks/mmm/kpis/div-hc-drug-delivery
See every metric in the 3M KPI table. Data updated Nov 2, 2026.